Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSV intra-articular injection for knee osteoarthritis
2009-017405-11Phase 2Active
- Sponsor
- Fundació Teknon
- Start
- Dec 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of MSV in knee osteoarthritis (OA), sponsored by Fundació Teknon. Primary endpoints: Efficacy at 6, 12, and 24 months, Feasibility and safety and 1 more. Started Dec 2009; status: active.
02
Drugs
MSV
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-017405-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017405-11.